{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Chromosomal microarray better informs brain tumor diagnosis: Robert Jenkins, M.D., Ph.D. ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/d88adff0\"></iframe>","width":"100%","height":180,"duration":1437,"description":"Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray assay outperforms other tests for brain tumor analysis. The microarray aligns with the World Health Organization's latest classification of central nervous system tumors.","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}